NMN
NAD+ Precursor | Cellular Energy & Longevity
Community Research
Join others researching NMN — share findings, ask questions, and learn from real experiences
Nicotinamide mononucleotide (NMN) is a naturally occurring nucleotide and a direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for cellular energy metabolism, DNA repair, sirtuin activation, and hundreds of enzymatic reactions. NAD+ levels decline significantly with age, and this decline is implicated in mitochondrial dysfunction, genomic instability, and many hallmarks of aging. NMN supplementation aims to restore NAD+ levels by providing the immediate substrate for the enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT), which catalyzes the final step of NAD+ biosynthesis in the salvage pathway. Popularized by Harvard geneticist David Sinclair, NMN has become one of the most widely studied and used longevity supplements. While animal data is extensive and compelling, human clinical trial data is still accumulating, with several trials showing increases in blood NAD+ levels and improvements in various biomarkers of aging.
NMN is converted to NAD+ via the NAD+ salvage pathway. After oral ingestion, NMN is absorbed in the gut, where it may be partially converted to nicotinamide riboside (NR) by the enzyme CD73 for cellular uptake, then re-phosphorylated intracellularly back to NMN. The enzyme NMNAT then converts NMN to NAD+. The resulting increase in NAD+ levels activates multiple longevity-associated pathways: sirtuins (SIRT1-7), a family of NAD+-dependent deacetylases that regulate mitochondrial biogenesis, DNA repair, inflammation, and stress resistance; PARP enzymes involved in DNA damage repair; and CD38/CD157 involved in immune cell signaling. By restoring NAD+ pools, NMN supplementation supports mitochondrial electron transport chain function and ATP production, enhances oxidative metabolism in skeletal muscle, and may counteract age-related metabolic decline. In the Slc12a8 transporter discovery, a dedicated NMN transporter was identified in the small intestine, supporting direct NMN absorption without prior conversion to NR.
Molecular Data
Research Indications
Replenishing NAD+ levels that decline 50% or more between ages 40 and 60. NAD+ is essential for over 500 enzymatic reactions and its decline is considered a hallmark of aging.
NAD+ is the required co-substrate for all seven sirtuin enzymes. SIRT1 and SIRT3 in particular regulate mitochondrial biogenesis, fat oxidation, and oxidative stress defense. NMN-mediated NAD+ elevation activates these longevity pathways.
NAD+ is consumed by PARP enzymes during DNA damage repair. Age-related NAD+ depletion impairs DNA repair capacity, potentially accelerating genomic instability. NMN supplementation may support PARP-mediated repair processes.
Human trials have shown NMN supplementation can improve skeletal muscle insulin sensitivity in prediabetic women. NAD+ is critical for metabolic flexibility and glucose utilization in muscle tissue.
NMN supports NAD+-dependent mitochondrial electron transport chain activity, improving ATP production efficiency. Animal studies show significant improvements in mitochondrial membrane potential and oxygen consumption rates.
Animal studies show NMN can reduce age-related weight gain and improve metabolic parameters. Human data on body composition effects is still limited but early results are suggestive of improved metabolic rate.
A human trial in recreational runners showed NMN supplementation improved aerobic capacity and ventilatory threshold. NAD+ is critical for oxidative phosphorylation during endurance exercise.
NAD+ supports mitochondrial recovery and reduces exercise-induced oxidative stress. Preliminary evidence suggests NMN may reduce perceived fatigue and support post-exercise recovery.
Animal studies demonstrate NMN can improve endothelial function, arterial elasticity, and blood flow. NAD+ supports nitric oxide signaling and vascular smooth muscle function. Human data is emerging.
NAD+ is critical for neuronal energy metabolism and synaptic function. Animal studies show NMN can improve cognitive function in aging mice and protect against neurodegeneration. Human cognitive trials are underway.
Dosing Protocols
Oral capsules and powder are the most common and well-studied delivery methods for NMN. Most human clinical trials have used oral administration at doses of 250-1250 mg per day. NMN is absorbed in the small intestine, with evidence for a dedicated transporter (Slc12a8). Oral bioavailability has been debated but blood NAD+ increases are consistently demonstrated in human trials.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| General Longevity Support | 250-500 mg/day | Once daily, morning | Oral capsule or powder |
| Aggressive NAD+ Restoration | 500-1000 mg/day | Once or twice daily | Oral capsule or powder |
Protocol Variations
Multiple approaches exist - compare before choosing
Different sources recommend different protocols for this peptide. Review each approach and consider your goals, tolerance, and experience level before choosing.
Sinclair Protocol
TraditionalSource: David Sinclair (Harvard Medical School)
"Aggressive NAD+ restoration combined with sirtuin-activating compounds for maximal longevity benefit. Based on the premise that NAD+ decline is a root cause of aging."
David Sinclair, a prominent aging researcher at Harvard, has publicly shared his personal supplementation regimen which centers on NMN as the primary NAD+ precursor. He combines NMN with resveratrol (a sirtuin activator) and other longevity compounds. His rationale is that NMN provides the NAD+ fuel while resveratrol steps on the sirtuin accelerator, creating synergistic activation of longevity pathways.
Key Points
- 1000 mg NMN per day -- on the higher end of studied doses
- Combined with 1000 mg resveratrol in yogurt (fat improves resveratrol absorption)
- Taken in the morning to align with circadian NAD+ biology
- Part of a broader longevity stack including metformin, vitamin D, vitamin K2
- Emphasis on combining NAD+ precursor with sirtuin activator for synergy
Dosing Schedule
Conservative Longevity Protocol
AlternativeSource: Clinical trial-based dosing
"Evidence-based dosing based on doses validated in human clinical trials, prioritizing demonstrated safety and efficacy data."
This protocol uses the dose range most commonly studied in published human clinical trials (250-500 mg/day). Multiple randomized controlled trials have demonstrated safety and NAD+ elevation at these doses with minimal side effects. Suitable for individuals who prefer to stay within the bounds of peer-reviewed clinical evidence.
Key Points
- 250-500 mg NMN per day -- aligns with most published human trial doses
- Single morning dose for simplicity and circadian alignment
- No requirement for combination with resveratrol or other compounds
- Dose can be titrated up from 250 mg based on subjective response
- Focuses on well-tolerated, clinically validated dosing
Dosing Schedule
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
- Mild gastrointestinal discomfort (nausea, bloating, diarrhea) at higher doses
- Flushing or warmth, particularly at doses above 500 mg
- Mild headache during initial supplementation period
- Increased energy that may affect sleep if taken too late in the day
Stop Signs - Discontinue if:
- Severe or persistent gastrointestinal symptoms not resolving with dose reduction
- Allergic reaction (hives, swelling, difficulty breathing)
- Unexplained skin rashes or systemic symptoms
Contraindications
- Known hypersensitivity to nicotinamide mononucleotide or related compounds
- Active cancer (theoretical concern: NAD+ supports rapidly dividing cells; consult oncologist)
- Pregnancy or breastfeeding (insufficient safety data)
- Severe hepatic impairment (altered NAD+ metabolism)
Quality Checklist
Good Signs
- Third-party tested for purity (>98% beta-NMN) with certificate of analysis available
- Enzymatically produced NMN (preferred over chemically synthesized for purity)
- Stored in opaque, moisture-proof packaging with desiccant
- Clear labeling of NMN content per serving, form (beta-NMN), and manufacturing date
- GMP-certified manufacturing facility
- Stable white crystalline powder with no discoloration or clumping
Warning Signs
- No third-party testing or certificate of analysis available
- Unusually low price compared to established brands (may indicate lower purity)
- Packaging does not protect from moisture or light
- Label does not specify beta-NMN form
Bad Signs
- Discolored, yellowed, or clumped powder (indicates degradation or moisture exposure)
- No labeling of NMN content, purity, or manufacturing information
- Product fails independent third-party testing for stated NMN content
- Contains significant impurities or undisclosed ingredients
- Stored in clear packaging exposed to light and heat
References
- Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic womenYoshino, M., Yoshino, J., Kayser, B.D., et al.Science (2021)
Randomized, double-blind, placebo-controlled trial in 25 postmenopausal prediabetic women. 250 mg/day NMN for 10 weeks increased muscle insulin signaling, insulin sensitivity, and muscle remodeling. First rigorous human trial demonstrating metabolic benefits of NMN supplementation.
- Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older menIgarashi, M., Nakagawa-Nagahama, Y., Miura, M., et al.NPJ Aging (2022)
Randomized controlled trial in 42 healthy older men. 250 mg/day NMN for 12 weeks significantly increased blood NAD+ metabolite levels and improved muscle function measures including gait speed and grip strength.
- Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind studyLiao, B., Zhao, Y., Wang, D., et al.Journal of the International Society of Sports Nutrition (2021)
Randomized, double-blind, placebo-controlled trial in 48 recreational runners. NMN supplementation (300-1200 mg/day for 6 weeks) improved aerobic capacity and ventilatory threshold in a dose-dependent manner, with higher doses producing greater improvements in oxygen utilization.
- Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese AdultsKim, M., Seol, J., Sato, T., et al.Nutrients (2022)
Randomized controlled trial in 108 older adults. 250 mg/day NMN for 12 weeks significantly reduced drowsiness and improved physical performance measures. Afternoon dosing specifically improved lower limb function and reduced fatigue.
- NAD+ metabolism and its roles in cellular processes during ageingCovarrubias, A.J., Perrone, R., Grozio, A., Verdin, E.Nature Reviews Molecular Cell Biology (2021)
Comprehensive review of NAD+ metabolism in aging. Documents the mechanisms of age-related NAD+ decline, the roles of NAD+-consuming enzymes (sirtuins, PARPs, CD38), and the therapeutic potential of NAD+ precursors including NMN and NR for age-related diseases.
Related Peptides
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.